Add BrightSurf on Google Email

Immunology Frontier Research Center (IFReC) - The University of Osaka


Curbing the neutrophil surge: New treatment offers hope for autoimmune diseases

Researchers from the University of Osaka have uncovered the first steps in the development of ANCA-associated glomerulonephritis, a kidney disease triggered by ANCAs. They found that injured kidney cells send signals attracting immune cells, including neutrophils, which drive inflammation in the early stages.

SourceImmunology Frontier Research Center (IFReC) - The University of Osaka·JournalJournal of Experimental Medicine·TypeExperimental study·DateOct 19, 2026

Recreating key features of the antibody factory in a dish

Scientists at the University of Osaka have developed a method to recreate human B cells with germinal center features using three immune signals, which closely match those found in human tonsils. This breakthrough could help improve vaccine-induced antibody responses and identify targets for autoimmune disease.

SourceImmunology Frontier Research Center (IFReC) - The University of Osaka·JournalScience Immunology·TypeExperimental study·DateSep 29, 2026

Immunity for the long haul: Why some antibodies are built to last

A team of researchers from the University of Osaka found that cells producing IgG1 antibodies have advantages over those producing IgM antibodies, including better antigen presentation, survival, and bone marrow migration. These advantages may lead to long-term immune protection and inform the development of more effective vaccines.

SourceImmunology Frontier Research Center (IFReC) - The University of Osaka·JournalScience Immunology·TypeExperimental study·DateSep 8, 2026

Taming overactive immune systems with antibodies: hope for autoimmune diseases

A multi-institutional team has discovered a novel immune regulatory mechanism mediated by antibodies that selectively shut down overactive immune responses. The 'immune-induced TCR-like antibody' (iTab) can reduce disease severity and delay its onset in a mouse model of autoimmune disease.

SourceImmunology Frontier Research Center (IFReC) - The University of Osaka·JournalNature Communications·TypeExperimental study·DateApr 22, 2026